Stockreport

Expanded Access to XHANCE with Addition to National Commercial Formularies [Yahoo! Finance]

OptiNose, Inc.  (OPTN) 
Last optinose, inc. earnings: 3/5 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.optinose.com
PDF throat (ENT) and allergy specialists, today announced that XHANCE ® (fluticasone propionate) has been added to Express Scripts' national formularies, including the Natio [Read more]